A team of researchers from ChristianaCare and the University of Delaware in the US has uncovered that a common genetic mutation in colorectal cancer disrupts the colon’s normal tissue renewal process, causing immature cells to build up, tissue structure to break down and early tumours to form. 

“This finding changes how we think about the very first steps of colon cancer,” said Bruce Boman, senior author of the study and a Senior Researcher at the Cawley Center for Translational Cancer Research at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute. “Instead of cancer starting because cells grow too fast, we found that it may start because the normal tissue renewal process slows down, creating a backup of cells that should have moved on. That backup sets the stage for tumours to grow.” 

The study was led by a multidisciplinary team of engineers, mathematicians, pathologists and tumour biologists from four research institutions. 

It shows how the natural process of renewal in the colon lining breaks down when a mutation occurs in a gene called APC, which is altered in about 90% of colorectal cancers. Rather than speeding up cell growth, the APC mutation creates a slowdown, or bottleneck, in the colon tissue’s renewal cycle. 

According to Boman, this slowdown causes dividing cells to pile up instead of moving through the system as they should. The result is the formation of adenomas, early growths that can become cancerous. 

“These findings are significant because they show how cancer-driving mutations change tissues that normally renew themselves nonstop,” Boman said. 

Resetting the renewal process

The findings also point toward a potential new approach to treatment. The researchers found evidence that the disrupted renewal process may trigger a chain reaction that allows pre-cancerous cells to keep copying themselves and fuelling tumour growth. 

By targeting this process, it may be possible to restore normal renewal timing and healthier tissue structure before cancer becomes established. 

“This study shows that cancer isn’t just about rogue cells, but about a system that’s fallen out of rhythm,” said Bruce Boman. “If we can reset that renewal process, we may be able to prevent or slow early tumour growth before it gains momentum.”

Diana Turner, Deputy Editor, DDW